Biologics And Biosimilars Market Size And Share

  • Report Code : TIPRE00008228
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Análisis de la cuota de mercado y oportunidades de productos biológicos y biosimilares 2025-2031

Buy Now

Biologics and Biosimilars Market Report Biologics and Biosimilars Market Scope and Analysis Biologics and Biosimilars Market Size and Share

Biologics and Biosimilars Market Report Analysis

Biologics and Biosimilars Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Pfizer Inc.
  • Intas Pharmaceuticals Ltd.
  • Biocon
  • Dr. Reddys Laboratories Ltd.
  • Sandoz International GmbH (Novartis division)
  • CELLTRION INC.
  • Amgen Inc.
  • STADA Arzneimittel AG
  • Apotex Inc.

Regional Overview

  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

By Producto
  • Proteínas recombinantes glicosiladas
  • Proteínas recombinantes no glicosiladas
By Indicación
  • Enfermedades crónicas
  • Oncología
  • Enfermedades autoinmunes
  • Enfermedades infecciosas
  • Trastornos de la sangre
  • Deficiencia de la hormona del crecimiento
  • Otras
By Geografía
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central